To further validate the expression of S100A2 in fibrotic diseases, samples were collected from four common kidney diseases: IgA nephropathy, hypertensive nephropathy, diabetic nephropathy, and lupus nephropathy. Here, S100A2 is linked to hypertensive nephropathy.